Celldex Therapeutics, Inc. - COM NEW (CLDX)

Historical Portfolio Holders from Q4 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
68.8 M
Holdings value Q1 2024
$2.89 B
Value change Q1 2024
+$374 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
188
Number of buys Q1 2024
123
Number of sells Q1 2024
-50
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.002%
CUSIP
15117B202
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 68.8 M $2.89 B +$374 M $41.97 190
2023 Q4 60.2 M $2.39 B +$344 M $39.66 158
2023 Q3 50.5 M $1.39 B -$662 K $27.52 138
2023 Q2 50.1 M $1.7 B +$19.5 M $33.93 144
2023 Q1 49.4 M $1.78 B +$25 M $35.98 155
2022 Q4 48.6 M $2.17 B -$3.35 M $44.57 158
2022 Q3 48.9 M $1.37 B +$39.8 M $28.11 140
2022 Q2 48.2 M $1.29 B -$45.8 M $26.96 149
2022 Q1 49.6 M $1.68 B +$106 M $34.06 154
2021 Q4 43.2 M $1.66 B +$98.8 M $38.64 166
2021 Q3 42.4 M $2.27 B +$390 M $53.99 153
2021 Q2 35.5 M $1.18 B +$48 M $33.44 123
2021 Q1 34.5 M $709 M -$32.5 M $20.60 109
2020 Q4 36.3 M $636 M +$70.5 M $17.52 113
2020 Q3 32.1 M $470 M +$66.7 M $14.83 80
2020 Q2 27.8 M $356 M +$311 M $13.00 60
2020 Q1 3.91 M $5.82 M -$78.4 K $1.66 27
2019 Q4 3.9 M $7.91 M +$19.4 K $2.23 30
2019 Q3 3.68 M $7.48 M +$711 K $2.13 38
2019 Q2 155 K $1.42 K -$443 K $2.69 4
2019 Q1 2.6 M $12 M +$11.5 M $4.92 38
2018 Q4 100 K $20 K +$20 K $0.20 1